Compare PODD & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PODD | BRKR |
|---|---|---|
| Founded | 2000 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.0B |
| IPO Year | 2007 | 2000 |
| Metric | PODD | BRKR |
|---|---|---|
| Price | $163.72 | $60.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 13 |
| Target Price | ★ $341.48 | $48.54 |
| AVG Volume (30 Days) | 1.4M | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.30 | 0.02 |
| Revenue | ★ $2,708,100,000.00 | $1,895,600,000.00 |
| Revenue This Year | $24.55 | $6.30 |
| Revenue Next Year | $19.18 | $3.81 |
| P/E Ratio | ★ $128.75 | $2,821.00 |
| Revenue Growth | ★ 30.73 | N/A |
| 52 Week Low | $138.79 | $28.53 |
| 52 Week High | $354.88 | $64.95 |
| Indicator | PODD | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 55.59 | 53.92 |
| Support Level | $141.67 | $54.42 |
| Resistance Level | $164.59 | $63.79 |
| Average True Range (ATR) | 6.04 | 3.19 |
| MACD | 0.83 | -0.47 |
| Stochastic Oscillator | 62.33 | 51.63 |
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.